Crossmark

Germline breast cancer susceptibility gene mutations and breast cancer outcomes

Crossref DOI link: https://doi.org/10.1186/s12885-018-4229-5

Published Online: 2018-03-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yong Alison

Jian, Jhih-Wei

Hung, Chen-Fang

Peng, Hung-Pin

Yang, Chi-Fan

Cheng, Hung-Chun Skye

Yang, An-Suei
Funding

Funding for this research was provided by:

Ministry of Science and Technology, Taiwan (MOST104-3114-Y-368-002, MOST106-0210-01-15-02, MOST106-0210-01-15-04)

Ministry of Health and Welfare (MOHW106-TDU-B-212-134004)
License Information

Text and Data Mining valid from 2018-03-22
More Information

Article History

Received: 17 August 2017

Accepted: 15 March 2018

First Online: 22 March 2018

Ethics approval and consent to participate

: The study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the Institutional Review Board Committee at Koo Foundation Sun Yat-Sen Cancer Center (case No. 20141222A). Written informed consent was obtained from each study participant.

: Not applicable.

: None of the authors have any competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.